EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A Multicenter Randomized Controlled Study on Pharmacokinetic‐Guided Vancomycin Use in Children With Severe Infections

Fuxiang He iD, Ya Yang, Bo Zhou, Chengcheng Li, Yu Feng, Xuexin Wang, Haifeng Liu, Yuhang Hu, Hongmin Fu, Yingbo Zou, Guoying Zhang, Jianli Chen und 4 weitere

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70309 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Fuxiang He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Minist…. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study is a multicenter, randomized controlled prospective trial aimed at evaluating the effects of two vancomycin pharmacokinetics/pharmacodynamics (PK/PD) parameters on clinical outcomes in children with different severe infections: trough concentration ( C min ) and the area under the curve (AUC 0‐24 /MIC). From January 2023 to December 2024, 472 pediatric patients from seven hospitals in Southwest China were included in the present study. These patients were randomly assigned to the AUC 0‐24 /MIC group or the C min group. After excluding 75 patients with renal function impairment caused by the primary disease, three patients with incomplete data, and one patient who received vancomycin for less than 48 h, 393 patients were finally enrolled for the present study. Then, the vancomycin treatment for children was evaluated using two PK/PD parameters, to guide clinical efficacy and monitor the incidence of adverse reactions: AUC 0‐24 /MIC, with a target value of 400–600 mg·h/L; trough concentration ( C min ), with a target value of 5–15 mg/L. The results indicated that there were no significant differences between the two groups in terms of daily dose, clinical efficacy, and adverse reactions. However, patients in the C min group had significantly shorter pediatric intensive care unit (PICU) stays ( Z = −2.05, p = 0.04), and patients in the 28‐day to 1‐year‐old subgroup had shorter mechanical ventilation times ( Z = −2.25, p = 0.024). Both C min and AUC 0‐24 /MIC were effective in guiding the vancomycin treatment for children with severe infections. However, patients in the C min group presented with advantages in PICU stay and ventilation duration. Trial Registration: China Clinical Trial Registry: ChiCTR2300067373

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsHumansMaleFemaleChild, PreschoolChildInfantProspective StudiesChinaTreatment OutcomeMicrobial Sensitivity TestsArea Under CurveDrug MonitoringIntensive Care Units, PediatricAdolescentSeverity of Illness Index

Stichwörter der Autor:innen

age groupsclinical efficacyinfectionspediatricspharmacokineticsvancomycin

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Emergency Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Cho…
  • Kunming Children's Hospital, Kunming, China.
  • Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Cho…
  • Zunyi First People's Hospital, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • Chengdu Women and Children's Central Hospital, Chengdu, China.
  • Guiyang Maternal and Child Health Care Hospital, Guiyang, Guizhou, China.

ORCID-Profile: Fuxiang He

Zitieren

APA

He, F., Yang, Y., Zhou, B., Li, C., Feng, Y., Wang, X., Liu, H., Hu, Y., Fu, H., Zou, Y., Zhang, G., Chen, J., Fu, Y., Xiao, S., Hu, L., & Liu, C. (2025). A Multicenter Randomized Controlled Study on Pharmacokinetic‐Guided Vancomycin Use in Children With Severe Infections. Clinical and Translational Science. https://doi.org/10.1111/cts.70309

Vancouver

He F, Yang Y, Zhou B, Li C, Feng Y, Wang X, et al. A Multicenter Randomized Controlled Study on Pharmacokinetic‐Guided Vancomycin Use in Children With Severe Infections. Clinical and Translational Science. 2025. doi:10.1111/cts.70309

BibTeX
@article{He2025,
  author = {He, Fuxiang and Yang, Ya and Zhou, Bo and Li, Chengcheng and Feng, Yu and Wang, Xuexin and Liu, Haifeng and Hu, Yuhang and Fu, Hongmin and Zou, Yingbo and Zhang, Guoying and Chen, Jianli and Fu, Yueqiang and Xiao, Shufang and Hu, Lan and Liu, Chengjun},
  title = {A Multicenter Randomized Controlled Study on Pharmacokinetic‐Guided Vancomycin Use in Children With Severe Infections},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70309}
}
Kostenlos starten →